External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis

To assess the efficacy and safety of pharmacological and electrical cardioversion for atrial fibrillation (AF).

This is a protocol.

You may also be interested in:

Clinical service organisation for adults with atrial fibrillation
Implantable cardiac monitors compared with conventional methods for the detection of atrial high-rate episodes in individuals with embolic stroke of undetermined source
Exercise-based cardiac rehabilitation for patients with atrial fibrillation
Screening people over 65 years of age for atrial fibrillation increases the rate of detection
Atrial fibrillation surgery for patients undergoing heart surgery

Health topics:

Heart & circulation > Arrythmias

Insurance medicine > Sick Leave > Heart & circulation

Published:

1 March 2019

Authors:

Providencia R, Chew D, Taylor J, Kukendra-Rajah K, Papageorgiou N, Ioannou A, Mead GE, Nevis IIF, Wilton SB, Lambiase P, Morillo CA

Primary Review Group:

Heart Group

See the full Review on

the Cochrane Library

►

Print
PDF
Citation
Providencia R, Chew D, Taylor J, Kukendra-Rajah K, Papageorgiou N, Ioannou A, Mead GE, Nevis IIF, Wilton SB, Lambiase P, Morillo CA. External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis. Cochrane Database of Systematic Reviews 2019, Issue 3. Art. No.: CD013255. DOI: 10.1002/14651858.CD013255

Don't show again

What role do you identify with the most?

Patient or care giver

Health practitioner

Researcher

Policy Maker

We are collecting information on visitors to our website to ensure Cochrane resources meet the needs of our users. Your data will be anonymised for processing, will be stored securely, and will not be shared with any third parties.